Home/Filings/4/0001213900-22-050082
4//SEC Filing

Claiborne Cary J 4

Accession 0001213900-22-050082

CIK 0001513525other

Filed

Aug 21, 8:00 PM ET

Accepted

Aug 22, 4:42 PM ET

Size

4.8 KB

Accession

0001213900-22-050082

Insider Transaction Report

Form 4
Period: 2022-08-18
Claiborne Cary J
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2022-08-18+1,000,0001,000,000 total
Footnotes (1)
  • [F1]These are Restricted Stock Units that vest monthly pro rata over the next 36 months.

Documents

1 file

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1
  • filerCIK 0001370930

Filing Metadata

Form type
4
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 4:42 PM ET
Size
4.8 KB